Drug Database · Clinicians

Ubidecarenone

Brands (1) QutanShow all

US brand (reference label): CO Q 10; not a Philippine-registered brand.

Metabolic cardiotonic PH FDA category

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID fd5e45ae-403f-44a2-abc0-343b9f550bdf, version date September 8, 2026 (CO Q 10 · Energique, Inc.). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • USES: May temporarily relieve poor memory.** **Claims based on traditional homeopathic practice, not accepted medical evidence.
US FDA label
Full indications and usage US FDA label

USES: May temporarily relieve poor memory.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Individual responses may vary, and this product may not work for everyone.

Dosing: Adult

Dosage and administration (US label) US FDA label

DIRECTIONS: • Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. • Consult a physician for use in children under 12 years of age.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Softgel capsule: 30 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Ubidecarenone as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Ubidecarenone
Package insert
QutanUbidecarenone (Coenzyme Q10)
30 mg Softgel CapsuleAlu/PVC Blister Pack x 10's (Box of 30's)
Rx
XL Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-6354
Aug 5, 2029

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

WARNINGS: Stop use and ask a doctor if symptoms persist for more than 7 days. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. DO NOT USE IF TAMPER EVIDENT SEAL IS BROKEN OR MISSING Store in a cool, dry place.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. CO Q 10 · Energique, Inc. [US FDA-approved label, version 5, September 8, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd5e45ae-403f-44a2-abc0-343b9f550bdf
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .